시장보고서

상품코드

1553641

소아용 백신 시장 규모, 점유율, 동향 분석 리포트 : 유형별, 기술별, 용도별, 지역별, 부문 예측(2024-2030년)

Pediatric Vaccines Market Size, Share & Trends Analysis Report By Type (Monovalent, Multivalent), By Technology (Live Attenuated Vaccines), By Application (Cancer), By Region, And Segment Forecasts, 2024 - 2030

발행일: 2024년 08월 | 리서치사:

Grand View Research | 페이지 정보: 영문 100 Pages | 배송안내 : 2-10일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

소아용 백신 시장의 성장과 동향 :

Grand View Research, Inc.의 최신 리포트에 따르면 세계의 소아용 백신 시장 규모는 2030년까지 494억 6,000만 달러에 달하며, CAGR은 4.1%를 기록할 것으로 예측됩니다.

백신 개발의 신흥 국가 시장 개척과 신제품 출시가 시장의 주요 촉진요인으로 작용하고 있습니다.

시장 점유율을 확대하기 위한 기업의 투자 증가는 성장을 가속할 것으로 예상됩니다. 투자 증가의 요인으로는 신흥 시장의 높은 성장 전망, 의사의 소아 예방접종 의무화, 유니세프 및 WHO와 같은 의료 기관이 주도하는 인식 개선 프로그램 등이 있습니다. 또한 예방접종에 대한 인식을 높이기 위한 정부의 구상이 증가하고 있는 것도 소아용 백신 시장을 촉진할 것으로 예상됩니다.

신규 보조제 및 치료용 백신 개발의 진전이 예측 기간 중 성장을 가속할 것으로 예상됩니다. 체내의 특정 작용기전을 표적으로 하는 새로운 분자에 대한 지속적인 연구는 암이나 지카 바이러스 감염과 같은 치명적인 질병에 대한 면역력을 제공하는 것을 목표로 하고 있습니다. 예를 들어 2016년 6월 Inovio Pharmaceuticals, Inc.는 GLS-5700이라는 이름의 지카 바이러스 DNA 백신에 대한 임상 1상 시험 개시를 발표했습니다.

소아용 백신 시장 보고서 하이라이트

유형별로는 사용량 증가와 각국 정부의 연구개발 활동 활성화 등의 요인으로 인해 일가백신이 가장 큰 부문으로 부상했습니다.
2023년 매출에서 결합형 백신이 압도적인 기술 부문을 형성할 것으로 예상됩니다. 이러한 백신의 높은 채택률과 감염성 질환 증가는 소아용 백신 시장을 주도하는 요인으로 작용하고 있습니다.
용도별로는 홍역, 유행성 이하선염, 풍진(MMR) 분야가 예측 기간 중 가장 빠른 CAGR 6.1%로 성장할 것으로 예상됩니다. 이는 예방접종률이 낮은 지역에서 예방접종을 받지 않은 어린이들의 특징인 홍역, 유행성이하선염, 풍진 사례가 여전히 존재하기 때문으로 분석됩니다.
북미는 2023년 가장 큰 매출 점유율을 차지했습니다. 북미가 소아용 백신 시장에서 우위를 점하고 있는 것은 업계 선두 기업의 현지 진출과 광범위한 R&D 활동 등의 요인에 기인합니다.
아시아태평양은 전염병의 유행과 대상 인구 증가로 인해 향후 10년간 유리한 성장세를 보일 것으로 예상됩니다.

소아용 백신 시장 점유율, 지역별, 2023년 및 2030년
북미
- 미국
- 캐나다
- 멕시코
유럽
- 영국
- 독일
- 프랑스
- 이탈리아
- 스페인
- 덴마크
- 스웨덴
- 노르웨이
아시아태평양
- 중국
- 일본
- 인도
- 한국
- 호주
- 태국
라틴아메리카
- 브라질
- 아르헨티나
중동 및 아프리카
- 사우디아라비아
- 아랍에미리트
- 남아프리카공화국
- 쿠웨이트

제8장 경쟁 구도

주요 시장 참여 기업에 의한 최근 동향과 영향 분석
기업 분류
기업 히트맵 분석
기업 개요
- AstraZeneca
- Sanofi
- GSK plc
- Pfizer, Inc.
- Zydus Group
- Indian Immunologicals Ltd.
- Serum Institute of India Pvt. Ltd.
- Panacea Biotec
- SINOVAC
- BIO-MED

KSA 24.09.25

Pediatric Vaccines Market Growth & Trends:

The global pediatric vaccines market size is expected to reach USD 49.46 billion by 2030, registering a CAGR of 4.1%, according to a new report by Grand View Research, Inc. Advancements in development of vaccines and new product launches are some of the major drivers of the market.

Increase in investments by companies to capture a larger market share is anticipated to propel growth. Some of the factors attributed to increase in investment are high growth prospects in the emerging market, immunization schedule mandated by doctors for children, and awareness programs led by UNICEF, WHO, and other healthcare organizations. Furthermore, increase in number of government initiatives for raising awareness about immunization is expected to boost the market for pediatric vaccines.

Advancements in development of novel adjuvants and therapeutic vaccines are expected to drive growth during the forecast period. Ongoing research in novel molecules targeted at specific mechanisms of action in the body is aimed at providing immunity against fatal diseases such as cancer and Zika virus disease. For instance, in June 2016, Inovio Pharmaceuticals, Inc. announced the initiation of phase I clinical trial for their Zika DNA vaccine named GLS-5700.

Pediatric Vaccines Market Report Highlights:

By type, monovalent emerged as the largest segment due to factors such as high usage and increase in initiatives for R&D activities supported by various governments.
Conjugate vaccines formed the dominant technology segment in terms of revenue in 2023. Higher adoption of these vaccines and increase in prevalence of infectious diseases contribute to its lead in the market for pediatric vaccines.
By application, the measles, mumps, and rubella (MMR) segment is projected to grow at the fastest CAGR of 6.1% over the forecast period. This is attributable to the fact that there are still cases of measles, mumps, and rubella which are characteristics of children who have not been vaccinated in areas with poor coverage.
North America held the largest revenue share in 2023. Its dominance in the market for pediatric vaccines is owing to factors such as local presence of major players in the industry and extensive R&D activities.
The Asia Pacific region is anticipated to witness lucrative growth over the next decade due to increase in prevalence of infectious diseases and a large target population.

Chapter 1. Methodology and Scope

1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
- 1.3.1. Information Procurement
- 1.3.2. Information or Data Analysis
- 1.3.3. Market Formulation & Data Visualization
- 1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
- 1.4.1. List of Data Sources

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights

Chapter 3. Pediatric Vaccines Market Variables, Trends, & Scope

3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
- 3.3.1. Market Drivers Analysis
- 3.3.2. Market Restraints Analysis
3.4. Pediatric Vaccines Market Analysis Tools
- 3.4.1. Porter's Analysis
  - 3.4.1.1. Bargaining power of the suppliers
  - 3.4.1.2. Bargaining power of the buyers
  - 3.4.1.3. Threats of substitution
  - 3.4.1.4. Threats from new entrants
  - 3.4.1.5. Competitive rivalry
- 3.4.2. PESTEL Analysis
  - 3.4.2.1. Political landscape
  - 3.4.2.2. Economic and Social landscape
  - 3.4.2.3. Technological landscape
  - 3.4.2.4. Environmental landscape
  - 3.4.2.5. Legal landscape

Chapter 4. Pediatric Vaccines Market: Type Estimates & Trend Analysis

4.1. Segment Dashboard
4.2. Pediatric Vaccines Market: Type Movement Analysis, 2023 & 2030 (USD Million)
4.3. Monovalent
- 4.3.1. Monovalent Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Multivalent
- 4.4.1. Multivalent Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Pediatric Vaccines Market: Technology Estimates & Trend Analysis

5.1. Segment Dashboard
5.2. Pediatric Vaccines Market: Technology Movement Analysis, 2023 & 2030 (USD Million)
5.3. Live Attenuated Vaccines
- 5.3.1. Live Attenuated Vaccines Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Inactivated Vaccines
- 5.4.1. Inactivated Vaccines Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Subunit Vaccines
- 5.5.1. Subunit Vaccines Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. Toxoid Vaccines
- 5.6.1. Toxoid Vaccines Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.7. Conjugate Vaccines
- 5.7.1. Conjugate Vaccines Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.8. Others
- 5.8.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Pediatric Vaccines Market: Application Estimates & Trend Analysis

6.1. Segment Dashboard
6.2. Pediatric Vaccines Market: Application Movement Analysis, 2023 & 2030 (USD Million)
6.3. Infectious Disease
- 6.3.1. Infectious Disease Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Cancer
- 6.4.1. Cancer Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Allergy
- 6.5.1. Allergy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Pneumococcal Diseases
- 6.6.1. Pneumococcal Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7. Influenza
- 6.7.1. Influenza Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.8. Measles, Mumps, and Rubella (MMR)
- 6.8.1. Measles, Mumps, and Rubella (MMR) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.9. Other Application
- 6.9.1. Other Application Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Pediatric Vaccines Market: Regional Estimates & Trend Analysis

7.1. Pediatric Vaccines Market Share, By Region, 2023 & 2030 (USD Million)
7.2. North America
- 7.2.1. North America Pediatric Vaccines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.2.2. U.S.
  - 7.2.2.1. U.S. Pediatric Vaccines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.2.3. Canada
  - 7.2.3.1. Canada Pediatric Vaccines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.2.4. Mexico
  - 7.2.4.1. Mexico Pediatric Vaccines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3. Europe
- 7.3.1. Europe Pediatric Vaccines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.2. UK
  - 7.3.2.1. UK Pediatric Vaccines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.3. Germany
  - 7.3.3.1. Germany Pediatric Vaccines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.4. France
  - 7.3.4.1. France Pediatric Vaccines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.5. Italy
  - 7.3.5.1. Italy Pediatric Vaccines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.6. Spain
  - 7.3.6.1. Spain Pediatric Vaccines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.7. Denmark
  - 7.3.7.1. Denmark Pediatric Vaccines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.8. Sweden
  - 7.3.8.1. Sweden Pediatric Vaccines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.9. Norway
  - 7.3.9.1. Norway Pediatric Vaccines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4. Asia Pacific
- 7.4.1. Asia Pacific Pediatric Vaccines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.2. China
  - 7.4.2.1. China Pediatric Vaccines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.3. Japan
  - 7.4.3.1. Japan Pediatric Vaccines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.4. India
  - 7.4.4.1. India Pediatric Vaccines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.5. South Korea
  - 7.4.5.1. South Korea Pediatric Vaccines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.6. Australia
  - 7.4.6.1. Australia Pediatric Vaccines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.7. Thailand
  - 7.4.7.1. Thailand Pediatric Vaccines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5. Latin America
- 7.5.1. Latin America Pediatric Vaccines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.2. Brazil
  - 7.5.2.1. Brazil Pediatric Vaccines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.3. Argentina
  - 7.5.3.1. Argentina Pediatric Vaccines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6. Middle East and Africa
- 7.6.1. Middle East and Africa Pediatric Vaccines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.2. Saudi Arabia
  - 7.6.2.1. Saudi Arabia Pediatric Vaccines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.3. UAE
  - 7.6.3.1. UAE Pediatric Vaccines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.4. South Africa
  - 7.6.4.1. South Africa Pediatric Vaccines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.5. Kuwait
  - 7.6.5.1. Kuwait Pediatric Vaccines Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

8.1. Recent Developments & Impact Analysis by Key Market Participants
8.2. Company Categorization
8.3. Company Heat Map Analysis
8.4. Company Profiles
- 8.4.1. AstraZeneca
  - 8.4.1.1. Participant's Overview
  - 8.4.1.2. Financial Performance
  - 8.4.1.3. Product Benchmarking
  - 8.4.1.4. Recent Developments/ Strategic Initiatives
- 8.4.2. Sanofi
  - 8.4.2.1. Participant's Overview
  - 8.4.2.2. Financial Performance
  - 8.4.2.3. Product Benchmarking
  - 8.4.2.4. Recent Developments/ Strategic Initiatives
- 8.4.3. GSK plc
  - 8.4.3.1. Participant's Overview
  - 8.4.3.2. Financial Performance
  - 8.4.3.3. Product Benchmarking
  - 8.4.3.4. Recent Developments/ Strategic Initiatives
- 8.4.4. Pfizer, Inc.
  - 8.4.4.1. Participant's Overview
  - 8.4.4.2. Financial Performance
  - 8.4.4.3. Product Benchmarking
  - 8.4.4.4. Recent Developments/ Strategic Initiatives
- 8.4.5. Zydus Group
  - 8.4.5.1. Participant's Overview
  - 8.4.5.2. Financial Performance
  - 8.4.5.3. Product Benchmarking
  - 8.4.5.4. Recent Developments/ Strategic Initiatives
- 8.4.6. Indian Immunologicals Ltd.
  - 8.4.6.1. Participant's Overview
  - 8.4.6.2. Financial Performance
  - 8.4.6.3. Product Benchmarking
  - 8.4.6.4. Recent Developments/ Strategic Initiatives
- 8.4.7. Serum Institute of India Pvt. Ltd.
  - 8.4.7.1. Participant's Overview
  - 8.4.7.2. Financial Performance
  - 8.4.7.3. Product Benchmarking
  - 8.4.7.4. Recent Developments/ Strategic Initiatives
- 8.4.8. Panacea Biotec
  - 8.4.8.1. Participant's Overview
  - 8.4.8.2. Financial Performance
  - 8.4.8.3. Product Benchmarking
  - 8.4.8.4. Recent Developments/ Strategic Initiatives
- 8.4.9. SINOVAC
  - 8.4.9.1. Participant's Overview
  - 8.4.9.2. Financial Performance
  - 8.4.9.3. Product Benchmarking
  - 8.4.9.4. Recent Developments/ Strategic Initiatives
- 8.4.10. BIO-MED
  - 8.4.10.1. Participant's Overview
  - 8.4.10.2. Financial Performance
  - 8.4.10.3. Product Benchmarking
  - 8.4.10.4. Recent Developments/ Strategic Initiatives

소아용 백신 시장 규모, 점유율, 동향 분석 리포트 : 유형별, 기술별, 용도별, 지역별, 부문 예측(2024-2030년)

Pediatric Vaccines Market Size, Share & Trends Analysis Report By Type (Monovalent, Multivalent), By Technology (Live Attenuated Vaccines), By Application (Cancer), By Region, And Segment Forecasts, 2024 - 2030

소아용 백신 시장의 성장과 동향 :

소아용 백신 시장 보고서 하이라이트

목차

제1장 조사 방법과 범위

제2장 개요

제3장 소아용 백신 시장의 변수, 동향, 범위

제4장 소아용 백신 시장 : 유형별 추정·동향 분석

제5장 소아용 백신 시장 : 기술별 추정·동향 분석

제6장 소아용 백신 시장 : 용도별 추정·동향 분석

제7장 소아용 백신 시장 : 지역별 추정·동향 분석